Cargando…

Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia

BACKGROUND: While epidemiological studies have reported a potential role for hypercholesterolemia (HCE) in osteoarthritis (OA), the association between HCE and OA has yet to be clarified. Adipose tissue is a primary locus for cholesterol metabolism and the presence of HCE reportedly causes adipose d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukai, Manabu, Uchida, Kentaro, Takano, Shotaro, Iwase, Dai, Aikawa, Jun, Inoue, Gen, Miyagi, Masayuki, Takaso, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001124/
https://www.ncbi.nlm.nih.gov/pubmed/29898737
http://dx.doi.org/10.1186/s12944-018-0792-7
_version_ 1783331922042159104
author Mukai, Manabu
Uchida, Kentaro
Takano, Shotaro
Iwase, Dai
Aikawa, Jun
Inoue, Gen
Miyagi, Masayuki
Takaso, Masashi
author_facet Mukai, Manabu
Uchida, Kentaro
Takano, Shotaro
Iwase, Dai
Aikawa, Jun
Inoue, Gen
Miyagi, Masayuki
Takaso, Masashi
author_sort Mukai, Manabu
collection PubMed
description BACKGROUND: While epidemiological studies have reported a potential role for hypercholesterolemia (HCE) in osteoarthritis (OA), the association between HCE and OA has yet to be clarified. Adipose tissue is a primary locus for cholesterol metabolism and the presence of HCE reportedly causes adipose dysfunction. The knee joint contains adipose tissue in the form of the infrapatellar fat pad (IPFP), which has been shown to contribute to the pathophysiology of OA in the knee via the secretion of inflammatory mediators. However, the effect of HCE on the expression of inflammatory mediators in the IPFP has not been elucidated. METHODS: IPFP and synovial tissues (ST) were extracted from 145 subjects with OA, diagnosed by radiography, during total knee arthroplasty. OA patients were divided into three groups according to their total cholesterol levels (Desirable, Borderline high and High) based on the National Cholesterol Education Program Adult Treatment Panel III (NCEPATP III). We examined the expression of cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES1), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 using real-time polymerase chain reaction and compared results among the Desirable, Borderline high and High groups. RESULTS: The mRNA expression levels of TNF-α, IL-1β, and IL-6 in ST and the IPFP were not significantly different among the three groups. COX-2 mRNA expression in ST and IPFP was likewise not different among the three groups. While the mRNA expression level of mPGES1 in ST was also not significantly different, that of mPGES1 in the IPFP was significantly lower in the High group than in the Desirable and Borderline high groups. CONCLUSION: mRNA levels of mPGES-1 are reduced in the IPFP of knee OA patients with HCE. Additional studies are need to clarify the effect of mPGES-1 down-regulation in OA pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0792-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6001124
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60011242018-06-26 Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia Mukai, Manabu Uchida, Kentaro Takano, Shotaro Iwase, Dai Aikawa, Jun Inoue, Gen Miyagi, Masayuki Takaso, Masashi Lipids Health Dis Research BACKGROUND: While epidemiological studies have reported a potential role for hypercholesterolemia (HCE) in osteoarthritis (OA), the association between HCE and OA has yet to be clarified. Adipose tissue is a primary locus for cholesterol metabolism and the presence of HCE reportedly causes adipose dysfunction. The knee joint contains adipose tissue in the form of the infrapatellar fat pad (IPFP), which has been shown to contribute to the pathophysiology of OA in the knee via the secretion of inflammatory mediators. However, the effect of HCE on the expression of inflammatory mediators in the IPFP has not been elucidated. METHODS: IPFP and synovial tissues (ST) were extracted from 145 subjects with OA, diagnosed by radiography, during total knee arthroplasty. OA patients were divided into three groups according to their total cholesterol levels (Desirable, Borderline high and High) based on the National Cholesterol Education Program Adult Treatment Panel III (NCEPATP III). We examined the expression of cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES1), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 using real-time polymerase chain reaction and compared results among the Desirable, Borderline high and High groups. RESULTS: The mRNA expression levels of TNF-α, IL-1β, and IL-6 in ST and the IPFP were not significantly different among the three groups. COX-2 mRNA expression in ST and IPFP was likewise not different among the three groups. While the mRNA expression level of mPGES1 in ST was also not significantly different, that of mPGES1 in the IPFP was significantly lower in the High group than in the Desirable and Borderline high groups. CONCLUSION: mRNA levels of mPGES-1 are reduced in the IPFP of knee OA patients with HCE. Additional studies are need to clarify the effect of mPGES-1 down-regulation in OA pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0792-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-13 /pmc/articles/PMC6001124/ /pubmed/29898737 http://dx.doi.org/10.1186/s12944-018-0792-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mukai, Manabu
Uchida, Kentaro
Takano, Shotaro
Iwase, Dai
Aikawa, Jun
Inoue, Gen
Miyagi, Masayuki
Takaso, Masashi
Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
title Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
title_full Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
title_fullStr Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
title_full_unstemmed Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
title_short Down-regulation of microsomal prostaglandin E2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
title_sort down-regulation of microsomal prostaglandin e2 synthase-1 in the infrapatellar fat pad of osteoarthritis patients with hypercholesterolemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001124/
https://www.ncbi.nlm.nih.gov/pubmed/29898737
http://dx.doi.org/10.1186/s12944-018-0792-7
work_keys_str_mv AT mukaimanabu downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT uchidakentaro downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT takanoshotaro downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT iwasedai downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT aikawajun downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT inouegen downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT miyagimasayuki downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia
AT takasomasashi downregulationofmicrosomalprostaglandine2synthase1intheinfrapatellarfatpadofosteoarthritispatientswithhypercholesterolemia